Recent Finacing
Recent Raise
HDT Bio develops nanoparticle RNA-delivery platforms and LION formulation/adjuvant technologies to create vaccines and immunotherapies, including nasal antiviral sprays and COVID-19 vaccine candidates.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at HDT Bio.
